Oculus negotiates $2.16 million at-the-market sales of common shares

Deal conducted by MLV to finance working capital, corporate purposes

By Devika Patel

Knoxville, Tenn., Aug. 12 – Oculus Innovative Sciences, Inc. will conduct a $2.16 million at-the-market issuance sales agreement with MLV & Co. LLC, according to a prospectus supplement filed Tuesday with the Securities and Exchange Commission.

MLV will be paid a 3% commission.

Proceeds will be used for working capital and general corporate purposes.

Oculus is a medical instruments company based in Petaluma, Calif., that makes tissue care products.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.